Cargando…
SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency
Autores principales: | Marcus, Nufar, Ashkenazi-Hoffnung, Liat, Ovadia, Adi, Dalal, Ilan, Yoffe, Siril, Kropach, Nesia, Zuckerman, Neta, Scheuerman, Oded |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117157/ https://www.ncbi.nlm.nih.gov/pubmed/35598866 http://dx.doi.org/10.1016/j.jaip.2022.05.004 |
Ejemplares similares
-
Reply to “SARS-CoV-2 reinfection or persistence among immunodeficient patients”
por: Marcus-Mandelblit, Nufar, et al.
Publicado: (2023) -
A host-protein signature is superior to other biomarkers for differentiating between bacterial and viral disease in patients with respiratory infection and fever without source: a prospective observational study
por: Ashkenazi-Hoffnung, Liat, et al.
Publicado: (2018) -
The Burden of COVID-19 in Children and Its Prevention by Vaccination: A Joint Statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases
por: Stein, Michal, et al.
Publicado: (2022) -
Navigating the New Reality: A Review of the Epidemiological, Clinical, and Microbiological Characteristics of Candida auris, with a Focus on Children
por: Ashkenazi-Hoffnung, Liat, et al.
Publicado: (2023) -
Potential Founder Variants in COL4A4 Identified in Bukharian Jews Linked to Autosomal Dominant and Autosomal Recessive Alport Syndrome
por: Levy, Michal, et al.
Publicado: (2023)